CoChat
Cited by 11

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Anti-platelet and tissue engineering approaches to biomaterial blood compatibilization: how well have these been translated into the clinic?

Irvine, Scott Alexander, Yun, Xia, Venkatraman, Subbu · 2012 · Drug Delivery and Translational Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13346-012-0077-z

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 57

  1. Deible CR, Petrosko P, et al. Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol. Biomaterials. 1999;20(2):101–9. · doi:10.1016/s0142-9612(98)00001-5
  2. Park K, Shim HS, Dewanjee MK, Eigler NL. In vitro and in vivo studies of PEO-grafted blood-contacting cardiovascular prostheses. J Biomater Sci Polym Ed. 2000;11(11):1121–34. · doi:10.1163/156856200744228
  3. Billinger M, Buddeberg F, Hubbell JA, et al. Polymer stent coating for prevention of neointimal hyperplasia. J Invasive Cardiol. 2006;18(9):423–6.
  4. Shin HS, Park K, Kim JH, et al. Biocompatible PEG grafting on DLC-coated nitinol alloy for vascular stents. J Bioact Compat Polym. 2009;24(4):316–28. · DOI
  5. Chang Y, Shih YJ, Ko CY, Jhong JF, Liu YL, Wei TC. Hemocompatibility of poly(vinylidene fluoride) membrane grafted with network-like and brush-like antifouling layer controlled via plasma-induced surface PEGylation. Langmuir. 2011;27(9):5445–55. · DOI
  6. Koh LB, Rodriguez I, Venkatraman SS. A novel nanostructured poly(lactic-co-glycollic acid)-multi-walled carbon nanotube composite for blood-contacting applications: thrombogenicity studies. Acta Biomater. 2009;5(9):3411–22. · DOI
  7. Koh LB, Rodriguez I, Venkatraman SS. Effect of topography of polymer surfaces on platelet adhesion. Biomaterials. 2009;31(7):1533–45. · DOI · Paper page
  8. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol. 2006;36:189–217. · DOI · Paper page
  9. Crouziera D, Follot S, et al. Carbon nanotubes induce inflammation but decrease the production of reactive oxygen species in lung. Toxicology. 2010;272(1–3):39–45. · DOI
  10. Koh LB, Rodriguez I, Venkatraman SS. Conformational behavior of fibrinogen on topographically modified polymer surfaces. Phys Chem Chem Phys. 2010;12:10301–8. · DOI
  11. Sun T, Hong Tan H, et al. No platelet can adhere—largely improved blood compatibility on nanostructured superhydrophobic surfaces. Small. 2005;10:959–63. · DOI · Paper page
  12. Venkatraman SS, Boey F. Release profiles in drug-eluting stents: issues and uncertainties. J Control Release. 2007;120:149–60. · DOI · Paper page
  13. Xia Y, Boey F, Venkatraman SS. Surface modification of poly(l-lactic acid) with biomolecules to promote endothelialization. Biointerphases. 2010;5:FA32–41. · DOI
  14. Sharkawi T, Darcos V, Vert M. Poly(dl-lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioabsorbable devices. J Biomed Mater Res A. 2011;98A:80–7. · DOI
  15. Lane DA, Macgregor IR, Michalski R, Kakkar VV. Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res. 1978;12(2):257–71. · doi:10.1016/0049-3848(78)90297-9
  16. Olsson P, Sanchez J, Mollnes TE, Riesenfeld J. On the blood compatibility of end-point immobilized heparin. J Biomater Sci Polym Ed. 2000;11:1261. · DOI
  17. Larsson O, Larm P, Olsson P. The search for thromboresistance using immobilized heparin. Ann N Y Acad Sci. 1987;516:102. · doi:10.1111/j.1749-6632.1987.tb33034.x
  18. Turner JS, Sefton MV. Immobilization of a lysine-terminated heparin to polyvinyl alcohol. J Biomater Sci Polym Ed. 1994;5:353. · doi:10.1163/156856294x00077
  19. Wang XH, Li DP, Wang WJ, et al. Covalent immobilization of chitosan and heparin on PLGA surface. Int J Biol Macromol. 2003;33(1–3):95–100. · DOI
  20. Meng S, Liu Z, et al. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system. Biomaterials. 2009;30(12):2276–83. · DOI · Paper page
  21. Murugesan S, Xie J, et al. Immobilization of heparin: approaches and applications. Curr Top Med Chem. 2008;8:80–100. · DOI · Paper page
  22. Larsson R, Larm O, et al. The search for thromboresistance using immobilized heparin. Ann N Y Acad Sci. 1987;516:102–15. · doi:10.1111/j.1749-6632.1987.tb33034.x
  23. Palanzo DA, Zarro DL, et al. Effect of Carmeda® BioActive Surface coating versus Trillium™ Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass. Perfusion. 2001;16:279–83. · DOI
  24. Gupta V, Aravamuthan BR, et al. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. J Invasive Cardiol. 2004;16:304–10.
  25. Thierry B, Winnik FM, et al. Biomimetic hemocompatible coatings through immobilization of hyaluronan derivatives on metal surfaces. Langmuir. 2008;24(20):11834–41. · doi:10.1021/la801359w
  26. Venkatraman SS, Boey F, Lao LL. Implanted cardiovascular polymers: natural, synthetic and bio-inspired. Prog Polym Sci. 2008;33(9):853–74. · DOI · Paper page
  27. Deutsch M, Meinart J, et al. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery. 1999;126:847–55. · DOI
  28. Deutsch M, Meinart J, et al. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J Vasc Surg. 2009;49:352–62. · DOI · Paper page
  29. Xia Y, Prawirasatya M, et al. Surface chemistry modulates endothelial cell retention on PLLA under shear stress: cell adhesion strengthening mechanism. J Tissue Eng Regen Med. 2012 (in press).
  30. Pawlowski K, Rittgers S, Schmidt S, Bowlin G. Endothelial cell seeding of polymeric vascular grafts. Front Biosci. 2004;9:1412–21. · DOI
  31. Bowlin GL, Meyer A, et al. The persistence of electrostatically seeded endothelial cell lining a small diameter expanded polytetrafluoroethylene graft. J Biomater Appl. 2001;16:157–73. · DOI
  32. Krawiek JT, Vorp DA. Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials. 2012;33:3388–400. · DOI
  33. Cho SW, Lim SH, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg. 2005;241:506–15. · DOI · Paper page
  34. Wu W, Allen R, Gao J, Wang Y. Artificial niche combining elastomeric substrate and platelets guides vascular differentiation of bone marrow mononuclear cells. Tissue Eng A. 2011;17:1979–92. · DOI
  35. Zhang L, Zhou J, Lu Q, Wei Y, Hu S. A novel small-diameter vascular graft: in vivo behaviour of biodegradable three-layered tubular scaffolds. Biotechnol Bioeng. 2008;99:1007–15. · DOI
  36. Allen JB, Khan S, Lapidos KA, Ameer GA. Toward engineering a human endothelium with circulating progenitor cells. Stem Cells. 2010;28:318–28. · DOI
  37. Chu CFL, Lu A, Iszowski M, Sipehia R. Enhanced growth of animal and human endothelial cells on biodegradable polymers. Biochim Biophys Acta. 1999;1472:479–85. · DOI
  38. Zhu Y, Gao C, Liu X, He T, Shen J. Immobilization of biomacromolecules onto aminolyzed poly(l-lactic acid) toward acceleration of endothelium regeneration. Tissue Eng. 2004;10:53–61. · DOI
  39. Zhu Y, Gao C, He T, Shen J. Endothelium regeneration on luminal surface of polyurethane vascular scaffold modified with diamine and covalently grafted with gelatin. Biomaterials. 2004;25:423–30. · DOI · Paper page
  40. Ruoslahti E, Pierschbacher MD. Arg-Gly-Asp: a versatile cell recognition signal. Cell. 1986;44:517–8. · DOI · Paper page
  41. Pierschbacher M, Hyman EG, Ruoslahti E. Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A. 1983;80:1224–7. · DOI · Paper page
  42. Hubbell JA, Massia SP, Desai NP, Drumheller PD. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Nat Biotechnol. 1991;9:568–72. · DOI · Paper page
  43. Jun HW, West JL. Modification of polyurethane urea with PEG and YISGR peptide to enhance endothelialization without platelet adhesion. J Biomed Mater Res B Appl Biomater. 2005;72B:131–9. · DOI
  44. Greisler HP, Klosak JJ, et al. Biomaterial pre-treatment with ECGF to augment endothelial cell proliferation. J Vasc Surg. 1987;5:393–9. · DOI
  45. Ashahara T, Murohara T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7. · DOI · Paper page
  46. Aoki J, Serruys PW, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34. J Am Coll Cardiol. 2005;45:1574–9. · DOI · Paper page
  47. den Dekker WK, Houtgraaf JH, et al. Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™ stent) designed to promote vascular healing by capture of circulating progenitor cells in CAD patients. Atherosclerosis. 2011;219:245–52. · doi:10.1016/j.atherosclerosis.2011.06.032
  48. Wendel HP, Avci-Adali M, Ziemer G. Endothelial progenitor cell capture stents—hype or hope? Int J Cardiol. 2010;145(1):115–7. · DOI
  49. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738–41. · DOI · Paper page
  50. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation. 2002;106:1199–204. · DOI · Paper page
  51. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403–9. · DOI · Paper page
  52. van Beusekom HMM, Ertas G, et al. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect neo-intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv. 2012;79:231–42. · DOI
  53. Damma P, Klomp M, et al. Duration of dual antiplatelet therapy and outcomes after coronary stenting with the Genous™ bio-engineered R stent in patients from the e-HEALING registry. Catheter Cardiovasc Interv. 2012;79:243–52. · doi:10.1002/ccd.23156
  54. Rossi ML, Zavalloni D, et al. The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol. 2010;141:e20–2. · doi:10.1016/j.ijcard.2008.11.134
  55. Nakazawa G, Granada JF, et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv. 2010;3(1):68–75. · DOI
  56. Hoffmann J, Paul A, Harwardt M, et al. Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J Biomed Mater Res A. 2004;84:614–21.
  57. Avci-Adali M, Paul A, Ziemer G, Wendel HP. New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialization of blood-contacting materials. Biomaterials. 2008;29:3936–45. · DOI

Cited by

See all 11

Metadata

Authors
Irvine, S. A., Yun, X., & Venkatraman, S.
Venue
Drug Delivery and Translational Research
Published
2012-09-18
Volume
2
Issue
5
Pages
384-397
ISSN
  • 2190-393X
  • 2190-3948
Cited by
11
References
2
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-platelet and tissue engineering approaches to biomaterial blood compatibilization: how well have these been translated into the clinic? https://app.cochat.ai/papers/10.1007/s13346-012-0077-z
The paper
Irvine, S. A., Yun, X., & Venkatraman, S. (2012). Anti-platelet and tissue engineering approaches to biomaterial blood compatibilization: how well have these been translated into the clinic? Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-012-0077-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.